126 related articles for article (PubMed ID: 31558353)
1. The vaginal cylinder: Misunderstood, misused, or trivial? An in-depth dosimetric and multiinstitutional outcome investigation.
Guy CL; Fields EC; Quinn BA; Fisher CM; Ladbury CJ; Romano KD; Todor D
Brachytherapy; 2019; 18(6):763-770. PubMed ID: 31558353
[TBL] [Abstract][Full Text] [Related]
2. Comparison of dosimetric and clinical outcomes between short- and long-channel cylinder applicators for vaginal brachytherapy in intermediate- and high-risk endometrial cancer.
Kharouta MZ; Pham N; Nieto K; Surucu M; Mysz ML; Albuquerque K; Winder A; Liotta M; Potkul RK; Small W; Harkenrider MM
Brachytherapy; 2018; 17(4):673-679. PubMed ID: 29759329
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic analysis of high-dose-rate (192)Ir vaginal cuff brachytherapy for endometrial cancer using a cylindrical target volume model and varied cancer cell distributions.
Zhang H; Donnelly ED; Strauss JB; Qi Y
Med Phys; 2016 Jan; 43(1):483. PubMed ID: 26745941
[TBL] [Abstract][Full Text] [Related]
4. Dosimetric impact of cylinder size in high-dose rate vaginal cuff brachytherapy (VCBT) for primary endometrial cancer.
Zhang H; Gopalakrishnan M; Lee P; Kang Z; Sathiaseelan V
J Appl Clin Med Phys; 2016 Sep; 17(5):262-272. PubMed ID: 27685113
[TBL] [Abstract][Full Text] [Related]
5. Effects of prescription depth, cylinder size, treatment length, tip space, and curved end on doses in high-dose-rate vaginal brachytherapy.
Li S; Aref I; Walker E; Movsas B
Int J Radiat Oncol Biol Phys; 2007 Mar; 67(4):1268-77. PubMed ID: 17336226
[TBL] [Abstract][Full Text] [Related]
6. A feasibility study of using advanced external beam techniques to create a vaginal cuff brachytherapy-like endometrial boost plan.
Grelewicz Z; Zerrusen B; Sathiaseelan V; Zhang H
Med Dosim; 2018 Spring; 43(1):30-38. PubMed ID: 28886961
[TBL] [Abstract][Full Text] [Related]
7. Optimized dose distribution of Gammamed plus vaginal cylinders.
Supe SS; Bijina TK; Varatharaj C; Shwetha B; Arunkumar T; Sathiyan S; Ganesh KM; Ravikumar M
Med Dosim; 2009; 34(1):20-5. PubMed ID: 19181251
[TBL] [Abstract][Full Text] [Related]
8. Postoperative intravaginal brachytherapy for endometrial cancer; dosimetric analysis of vaginal colpostats and cylinder applicators.
Kim RY; Pareek P; Duan J; Murshed H; Brezovich I
Brachytherapy; 2002; 1(3):138-44. PubMed ID: 15090276
[TBL] [Abstract][Full Text] [Related]
9. Impact of vaginal cylinder diameter on outcomes following brachytherapy for early stage endometrial cancer.
Qian JM; Stahl JM; Young MR; Ratner E; Damast S
J Gynecol Oncol; 2017 Nov; 28(6):e84. PubMed ID: 29027402
[TBL] [Abstract][Full Text] [Related]
10. Dosimetric advantages of using multichannel balloons compared to single-channel cylinders for high-dose-rate vaginal cuff brachytherapy.
Hou X; Liu A; Zhang F; Wong J; Chen YJ
Brachytherapy; 2016; 15(4):471-476. PubMed ID: 27066994
[TBL] [Abstract][Full Text] [Related]
11. Design and Development of In-House Multichannel Applicator for HDR Vaginal Brachytherapy and Dosimetric Comparision with Single Channel Applicator.
Govindaraj K; Shanmugam S; Sampathrajan S
Asian Pac J Cancer Prev; 2019 Dec; 20(12):3805-3810. PubMed ID: 31870125
[TBL] [Abstract][Full Text] [Related]
12. American Brachytherapy Society survey regarding practice patterns of postoperative irradiation for endometrial cancer: current status of vaginal brachytherapy.
Small W; Erickson B; Kwakwa F
Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1502-7. PubMed ID: 16109462
[TBL] [Abstract][Full Text] [Related]
13. Vaginal brachytherapy alone: an alternative to adjuvant whole pelvis radiation for early stage endometrial cancer.
Jolly S; Vargas C; Kumar T; Weiner S; Brabbins D; Chen P; Floyd W; Martinez AA
Gynecol Oncol; 2005 Jun; 97(3):887-92. PubMed ID: 15943991
[TBL] [Abstract][Full Text] [Related]
14. Do vaginal recurrence rates differ among adjuvant vaginal brachytherapy regimens in early-stage endometrial cancer?
Ager BJ; Francis SR; Do OA; Huang YJ; Soisson AP; Dodson MK; Werner TL; Sause WT; Grant JD; Gaffney DK
Brachytherapy; 2019; 18(4):453-461. PubMed ID: 31005603
[TBL] [Abstract][Full Text] [Related]
15. Image-based 3D treatment planning for vaginal cylinder brachytherapy: dosimetric effects of bladder filling on organs at risk.
Hung J; Shen S; De Los Santos JF; Kim RY
Int J Radiat Oncol Biol Phys; 2012 Jul; 83(3):980-5. PubMed ID: 22138458
[TBL] [Abstract][Full Text] [Related]
16. The use and advantages of a multichannel vaginal cylinder in high-dose-rate brachytherapy.
Demanes DJ; Rege S; Rodriquez RR; Schutz KL; Altieri GA; Wong T
Int J Radiat Oncol Biol Phys; 1999 Apr; 44(1):211-9. PubMed ID: 10219816
[TBL] [Abstract][Full Text] [Related]
17. A dosimetric analysis of intensity-modulated radiation therapy (IMRT) as an alternative to adjuvant high-dose-rate (HDR) brachytherapy in early endometrial cancer patients.
Aydogan B; Mundt AJ; Smith BD; Mell LK; Wang S; Sutton H; Roeske JC
Int J Radiat Oncol Biol Phys; 2006 May; 65(1):266-73. PubMed ID: 16618581
[TBL] [Abstract][Full Text] [Related]
18. Low-dose adjuvant vaginal cylinder brachytherapy for early-stage non-endometrioid endometrial cancer: recurrence risk and survival outcomes.
Smart A; Buscariollo D; Alban G; Buzurovic I; Cheng T; Pretz J; Krechmer B; King M; Lee L
Int J Gynecol Cancer; 2020 Dec; 30(12):1908-1914. PubMed ID: 32655012
[TBL] [Abstract][Full Text] [Related]
19. Dosimetric comparison of bladder, rectal, and vaginal surface doses between ovoids and cylinder-based vaginal brachytherapy in carcinoma of the endometrium.
Kumar NP; Kumar A; Jayaprakash PG; Raghukumar P; James FV
J Cancer Res Ther; 2018; 14(6):1191-1195. PubMed ID: 30488828
[TBL] [Abstract][Full Text] [Related]
20. Comparing organ-at-risk doses for high-dose-rate vaginal brachytherapy between three different planning workflows.
Gruhl JD; Zheng D; Longo JL; Enke C; Wahl AO
Brachytherapy; 2017; 16(2):373-377. PubMed ID: 28039010
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
